Revvity (RVTY) Current Deferred Revenue (2014 - 2016)
Revvity's (RVTY) quarterly Current Deferred Revenue came in at $163.2 million in Q1 2016, down 3.41% YoY from $168.9 million in Q1 2015, and down 3.41% on a QoQ basis from $168.9 million in Q4 2014.
Revvity (RVTY) Current Deferred Revenue (2014 - 2016) Analysis & Trends
Revvity (RVTY) has 2 years of Current Deferred Revenue data on file, last reported at $163.2 million in Q1 2016.
- Quarterly Current Deferred Revenue fell 3.41% year-over-year to $163.2 million in Q1 2016, while the trailing twelve-month figure through Jan 2016 was $163.2 million (down 3.41% YoY) and the FY2016 annual result came in at $163.2 million, down 3.41% from the prior year.
- Current Deferred Revenue slipped to $163.2 million in Q1 2016, from $168.9 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $168.9 million in Q4 2014 to a low of $163.2 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 3, 2016 | 163.17 Mn |
| Dec 28, 2014 | 168.93 Mn |